Key result
Implantable cardioverter defibrillators are cost-effective in reducing sudden cardiac death and all-cause mortality, though barriers remain in translating guidelines into clinical practice.
Why the study?
Does the implantable cardioverter defibrillator reduce sudden cardiac death and all-cause mortality?
Population
Patients at risk of sudden cardiac death
Design
Review
Authors
Loading...
Barriers to guideline implementation persist; leaves open optimal strategies to improve real-world ICD uptake.
Does the implantable cardioverter defibrillator reduce sudden cardiac death and all-cause mortality?
While ICDs are cost-effective in reducing sudden cardiac death and all-cause mortality, significant barriers prevent full implementation of existing guidelines in clinical practice.
Rajabali et al. (2013) conducted a review in Sudden cardiac death. Implantable cardioverter defibrillator (ICD) was evaluated. Implantable cardioverter defibrillators are cost-effective in reducing sudden cardiac death and all-cause mortality, though barriers remain in translating guidelines into clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: